Markus Hutterer

Markus Hutterer

UNVERIFIED PROFILE

Are you Markus Hutterer?   Register this Author

Register author
Markus Hutterer

Markus Hutterer

Publications by authors named "Markus Hutterer"

Are you Markus Hutterer?   Register this Author

29Publications

441Reads

-Profile Views

Information needs and requirements in patients with brain tumours and their relatives.

J Neurooncol 2018 Jun 7;138(2):407-415. Epub 2018 Mar 7.

Department of Neurology and Wilhelm Sander-Neuro-Oncology Unit, University of Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2811-yDOI Listing
June 2018

Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients.

Biotechnol Rep (Amst) 2018 Jun 17;18:e00252. Epub 2018 Apr 17.

Institute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg, Paracelsus Medical University, Strubergasse 21, A-5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.btre.2018.e00252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989588PMC
June 2018

AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.

Clin Nucl Med 2017 Dec;42(12):e506-e508

From the *Department of Neurology 1, NeuroMed Campus, Kepler University Hospital, Linz, Austria; †Department of Neurology, ‡Wilhelm Sander Neurooncology Unit, and Departments of §Neuropathology and ∥Nuclear Medicine, University of Regensburg Medical School, Regensburg; ¶Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich; **Department of Neurology, University of Cologne, Cologne; ††Center of Integrated Oncology, Universities of Cologne and Bonn, Cologne; and ‡‡Department of Nuclear Medicine, University of Aachen, Aachen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001873DOI Listing
December 2017

Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab.

J Neurooncol 2016 Mar 31;127(1):191-200. Epub 2015 Dec 31.

Department of Neurology and Wilhelm Sander-NeuroOncology Unit, University of Regensburg Medical School, Universitätsstraße 84, 93053, Regensburg, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-015-2031-7
Publisher Site
http://dx.doi.org/10.1007/s11060-015-2031-7DOI Listing
March 2016

Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma.

Anticancer Res 2016 Mar;36(3):899-905

Department of Neurology, University Hospital, University of Erlangen-Nürnberg, Erlangen, Germany

View Article

Download full-text PDF

Source
March 2016

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.

Neuro Oncol 2015 Jun 27;17(6):784-800. Epub 2014 Dec 27.

Department of Neurology and Wilhelm-Sander Neuro-Oncology Unit, University Hospital and Medical School, Regensburg, Germany (M.H., P.H.); Neuroradiology, Department of Radiology, University Hospital Bonn, Bonn, Germany (E.H.); Regensburg Medical Image Computing, Ostbayerische Technische Hochschule Regensburg, Regensburg, Germany (C.P.); Department of Neurosurgery, University Hospital and Medical School, Regensburg, Germany (M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483117PMC
June 2015

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Neuropathol Appl Neurobiol 2015 Feb;41(2):e41-55

Institute of Neurology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center CNS Tumors Unit, Medical University of Vienna, Vienna, Austria; Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nan.12185DOI Listing
February 2015

An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.

PLoS One 2014 23;9(4):e95830. Epub 2014 Apr 23.

Department of Neurology, Innsbruck Medical University, Innsbruck, Austria; Department of Neurology and Wilhelm-Sander Neurooncology Unity, University Hospital and Medical School Regensburg, Regensburg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0095830PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997484PMC
January 2015

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.

Neurology 2014 May 11;82(19):1684-92. Epub 2014 Apr 11.

From the Departments of Neurology (M.N., M.H., G.S.) and Medical Statistics, Informatics and Health Economics (G.G.), Innsbruck Medical University, Austria; the Department of Neurooncology (B.W., W.W.), Neurology Clinic and National Center for Tumor Diseases, and the Department of Neuroradiology (M.N., M.B., A.R.), University of Heidelberg; the Department of Neurology (M.H.), Regensburg Medical University; the Department of Radiology (H.P.S.), the Clinical Cooperation Unit Neurooncology (B.W., W.W.), and Department of Radiology, Neurooncologic Imaging (E012) (A.R.), German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000402DOI Listing
May 2014

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Neuro Oncol 2013 Mar 17;15(3):341-51. Epub 2013 Jan 17.

Department of Neurology, Wilhelm-Sander Neurooncology Therapy Unit, University Hospital of Regensburg, Universitätsstrasse 84, D-93053 Regensburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578481PMC
March 2013

[Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas].

Wien Med Wochenschr 2011 Jan;161(1-2):6-12

Department für Psychiatrie und Psychotherapie, Medizinische Universität Innsbruck, Innsbruck, Österreich.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10354-011-0872-z
Publisher Site
http://dx.doi.org/10.1007/s10354-011-0872-zDOI Listing
January 2011

The impact of the DNA-repair gene MGMT in malignant gliomas.

Authors:
Markus Hutterer

Neuroepidemiology 2009 8;32(1):30-1. Epub 2008 Nov 8.

Neurooncology Group, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/170089
Publisher Site
http://dx.doi.org/10.1159/000170089DOI Listing
April 2010

Do neurooncological patients and their significant others agree on quality of life ratings?

Health Qual Life Outcomes 2009 Oct 9;7:87. Epub 2009 Oct 9.

Department of Psychiatry and Psychotherapy, Innsbruck Medical University, Anichstr,35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7525-7-87DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770559PMC
October 2009

Elderly patients with glioblastoma multiforme--an underestimated subpopulation?

Authors:
Markus Hutterer

Neuroepidemiology 2009 27;33(1):23-4. Epub 2009 Mar 27.

Department of Neurology, Neuro-Oncology Group, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000210018DOI Listing
August 2009

HER3 is a determinant for poor prognosis in melanoma.

Clin Cancer Res 2008 Aug;14(16):5188-97

Department of Molecular Biology, Max-Planck Institute of Biochemistry, Munich, Germany.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-0186DOI Listing
August 2008

Molecular therapies for malignant glioma.

Wien Med Wochenschr 2006 Jun;156(11-12):351-63

Department of Neurology, Neuro-Oncology Group, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10354-006-0308-3DOI Listing
June 2006